首页> 美国卫生研究院文献>International Journal of Oncology >WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor although the role of variant 4 remains unclear
【2h】

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor although the role of variant 4 remains unclear

机译:WWOX mRNA在上皮性卵巢癌中的表达谱支持WWOX变体1作为肿瘤抑制因子的作用尽管变体4的作用仍不清楚

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

WWOX is a candidate tumour suppressor gene that exhibits LOH or homozygous deletion in several tumour types. As well as the predominant full-length transcript (variant 1) there also exist alternatively spliced transcripts found previously only in malignant tissue. It has been suggested that proteins encoded by these variants may interfere with normal WWOX function in a dominant negative fashion. The most prevalent alternate transcript demonstrated in ovarian cancer is variant 4, which lacks exons 6-8. Here, we report the first comparison of the mRNA expression of WWOX variants 1 and 4 in human ovarian tumours and normal ovaries and correlate expression with clinical data. We demonstrate significantly lower WWOX variant 1 expression in tumours than in normal ovaries. This reduction was not associated with any specific clinical subgroup. Variant 4 was expressed at >low levels, and significantly associated with high grade and advanced stage ovarian cancer. Furthermore, tumours co-expressing variant 4 and relatively high levels of variant 1 showed significantly worse survival than tumours expressing variant 1 alone. However, variant 4 was also frequently identified in non-malignant ovarian tissue. These results support the role of WWOX variant 1 as a suppressor of ovarian tumouri-genesis, but the role of variant 4 remains speculative.
机译:WWOX是候选的抑癌基因,在几种肿瘤类型中均表现出LOH或纯合缺失。除主要的全长转录本(变体1)外,还存在以前仅在恶性组织中发现的选择性剪接的转录本。已经提出由这些变体编码的蛋白质可能以显性负性方式干扰正常的WWOX功能。卵巢癌中显示的最普遍的替代转录本是变体4,它缺少6-8号外显子。在这里,我们报告人类卵巢肿瘤和正常卵巢中WWOX变体1和4的mRNA表达的首次比较,并将其表达与临床数据相关联。我们证明在肿瘤中WWOX变异1表达明显低于正常卵巢。这种减少与任何特定的临床亚组无关。变体4以>低水平表达,并与高级别和晚期卵巢癌显着相关。此外,与单独表达变体1的肿瘤相比,共表达变体4和相对较高水平的变体1的肿瘤显示生存率明显降低。但是,在非恶性卵巢组织中也经常发现变异体4。这些结果支持了WWOX变体1作为卵巢肿瘤发生抑制剂的作用,但变体4的作用仍是推测性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号